UnitedHealth Group announces $2.21 per share dividend

NEW YORK - UnitedHealth Group (NYSE:UNH) announced Wednesday that its board of directors has authorized a quarterly cash dividend of $2.21 per share, payable on September 23, 2025.

The dividend will be distributed to shareholders of record as of the close of business on September 15, 2025, according to a company press release.

UnitedHealth Group operates through two main business segments: Optum, which provides technology-enabled healthcare services, and UnitedHealthcare, which offers health benefit plans and insurance coverage.

The company, headquartered in Minnesota, is one of the largest healthcare companies in the United States by revenue and market capitalization. UnitedHealth Group is a component of the Dow Jones Industrial Average.

The dividend announcement represents the company’s ongoing commitment to returning value to shareholders while maintaining its position in the healthcare sector. Despite a challenging six-month period with shares down 50.2%, InvestingPro’s Fair Value analysis suggests the stock is currently undervalued. Access the comprehensive Pro Research Report for detailed insights into UnitedHealth’s financial health and growth prospects.

In other recent news, UnitedHealth Group has been the focus of several analyst reports and corporate developments. Piper Sandler has reiterated its Overweight rating on UnitedHealth, maintaining a price target of $280, following a meeting with the company’s leadership. Similarly, UBS has reaffirmed its Buy rating with a $330 target, highlighting UnitedHealth’s "return to basics approach" after a comprehensive business review. In contrast, Bernstein SocGen has lowered its price target to $337 from $377, citing a "lower earnings starting point" for 2025, though it remains optimistic about the company’s growth potential.

Additionally, UnitedHealth has made a significant change in its executive team by appointing Wayne S. DeVeydt as the new Chief Financial Officer, effective September 2. This appointment is part of broader leadership changes, with the outgoing CFO, John F. Rex, transitioning to a strategic advisor role. These updates reflect UnitedHealth’s ongoing strategic adjustments and analyst perspectives on its future performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.